Chong Kun Dang's Herbal Ingredient Periodontal Disease Treatment 'EtonQ Plus'... Applied Patent Method

[Asia Economy Reporter Seo So-jeong] Chong Kun Dang's periodontal disease treatment 'EtonQ Plus' is receiving positive responses in the market due to its improved medication convenience.

EtonQ Plus is a herbal compound medicine that adds Magnolia officinalis extract to EtonQ, a single formulation of Zea mays silk quantitative extract.

The main ingredient, Zea mays silk quantitative extract, helps regenerate the periodontal ligament, preventing tooth mobility and reconstructing the alveolar bone to strengthen the foundation within the gums. Magnolia officinalis extract has excellent antibacterial and anti-inflammatory effects against the bacteria causing periodontal disease, enhancing resistance to gum inflammation.

The company explained that this product is a herbal ingredient treatment with no side effects even with long-term use.

By applying a patented tablet size reduction technology independently developed by Chong Kun Dang, the product reduces the tablet size to the smallest among currently available products with the same ingredients, shortening the disintegration time of the medicine and improving medication convenience for middle-aged and elderly patients who take multiple drugs simultaneously.

A Chong Kun Dang official said, "Many patients with periodontal disease take medication long-term, and adherence to dosage and administration greatly affects treatment. EtonQ Plus, which improves medication convenience and has proven safety, will greatly help in treating periodontal disease."